Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026

Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026

Official guideline text: EMA ↗

Brief written by VigiEye from the company's press release. Claims are the company's own. AI-assisted; check the source before acting.

More Pharmacovigilance All →

PharmacovigilanceOfficial

Medline details repair and replace programme for recalled beds, rails, mattresses and accessories

🇺🇸 FDA MedWatch · Fri 13 Nov 2026

PharmacovigilanceOfficial

PRAC publishes final EU-language translations of phenobarbital product information in targeted signal procedure

🇪🇺 EMA · PRAC · Fri 13 Nov 2026

PharmacovigilanceOfficial

EMA page on veterinary signal management details phenobarbital review and updated MAH templates

🇪🇺 EMA · PRAC · Fri 13 Nov 2026

PharmacovigilanceOfficial

EMA publishes draft veterinary PV guideline listing medically important VeDDRA terms

🇪🇺 EMA · Fri 13 Nov 2026

PharmacovigilanceOfficial

EMA opens consultation on medically important VeDDRA terms list for veterinary pharmacovigilance

🇪🇺 EMA · Fri 13 Nov 2026

PharmacovigilanceOfficial

FTC sues to block Covetrus's $3.5bn acquisition of veterinary distributor MWI

🇺🇸 FTC · Fri 13 Nov 2026